Loading clinical trials...
Loading clinical trials...
Master Protocol for Mantle Cell Lymphoma A Multicenter Phase II Trial Testing Gemcitabine for the Treatment of Patients With Newly Diagnosed, Relapsed or Chemotherapy Resistant Mantle Cell Lymphoma
Conditions
Interventions
gemcitabine hydrochloride
Locations
16
Switzerland
Kantonspital Aarau
Aarau, Switzerland
Baden, Switzerland
Kantonsspital Baden
Baden, Switzerland
Oncology Institute of Southern Switzerland
Bellinzona, Switzerland
Spital Buelach
Bülach, Switzerland
Kantonsspital - St. Gallen
Sankt Gallen, Switzerland
Start Date
June 1, 2005
Primary Completion Date
March 1, 2006
Completion Date
March 1, 2006
Last Updated
June 5, 2012
NCT05139017
NCT06263491
NCT07388563
NCT06337318
NCT05529069
NCT06189391
Lead Sponsor
Swiss Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions